MoneyWorks4Me

The sales declined to Rs. 911.07 millions for the March 2023 quarter as compared to Rs. 1209.56 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2023 is Rs. -43.86 millions as compared to Net Profit of Rs. 66.91 millions of corresponding quarter ended March 2022The company reported a degrowth in operating Profit to 5.35 millions from 101.99 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 911.07 1209.56 -24.68 3722.53 4510.68 -17.47 3722.53 4510.68 -17.47
Other Income 2.92 0.00 0.00 4.36 0.89 389.89 4.36 0.89 389.89
PBIDT 5.35 101.99 -94.75 259.54 491.45 -47.19 259.54 491.45 -47.19
Interest 34.34 25.34 35.52 127.51 111.62 14.24 127.51 111.62 14.24
PBDT -28.99 76.65 -137.82 132.03 379.83 -65.24 132.03 379.83 -65.24
Depreciation 27.50 26.87 2.34 109.89 102.49 7.22 109.89 102.49 7.22
PBT -56.49 49.78 -213.48 22.14 277.34 -92.02 22.14 277.34 -92.02
TAX -12.63 -17.13 -26.27 9.44 80.76 -88.31 9.44 80.76 -88.31
Deferred Tax 10.20 -30.18 -133.80 9.70 -7.32 -232.51 9.70 -7.32 -232.51
PAT -43.86 66.91 -165.55 12.70 196.58 -93.54 12.70 196.58 -93.54
Equity 158.28 158.28 0.00 158.28 158.28 0.00 158.28 158.28 0.00
PBIDTM(%) 0.59 8.43 -93.04 6.97 10.90 -36.01 6.97 10.90 -36.01
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..